Neuromuscular blockade by immunoglobulin G from patients with Miller Fisher syndrome

Annals of the New York Academy of Sciences

Volumn 841, Issue , 1998, Pages 659-669

  Buchwald, Brigitte ^a   Dudel, Josef ^b   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHOLINERGIC RECEPTOR; COMPLEMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ACTION POTENTIAL; ANIMAL TISSUE; CALCIUM TRANSPORT; CASE REPORT; CONFERENCE PAPER; CONTROLLED STUDY; ENDPLATE POTENTIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOCYTOSIS; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN TISSUE; MOTOR NERVE; MOUSE; MUSCLE WEAKNESS; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PLASMAPHERESIS; RADIOIMMUNOASSAY; SUBCLAVIAN STEAL SYNDROME;

ACRONICTA LEPORINA; ANIMALIA; MARTES PENNANTI;

EID: 0031879331     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb10999.x     Document Type: Conference Paper

References (22)

1. FISHER, M. 1956. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia, and areflexia). N. Engl. J. Med. 255: 57-65.
2. ROBERTS, M., H. WILLISON, A. VINCENT & J. NEWSOM-DAVIS. 1994. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 343: 454-455.
3. YUKI, N., S. SATO, S. TSUJI, T. OHSAWA & T. MIYATAKE. 1993. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology 43: 414-417.
4. BUCHWALD, B., A. WEISHAUPT, K. V. TOYKA & J. DUDEL. 1995. Immunoglobulin G from patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice. Neurosci. Lett. 201: 163-166.
5. ENDERS, U., H. KARCH, K. V. TOYKA, M. MICHELS, J. ZIELASEK, M. PETTE, J. HEESEMANN & H-P. HARTUNG. 1993. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34: 136-144.
6. BESINGER, U., K. V. TOYKA, M. HOMBERG, K. HEININGER, R. HOHLFELD & A. FATEH-MOGHADAM. 1983. Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking against acetylcholine receptors with changes in disease severity. Neurology 33(10): 1316-1321.
7. 4. Nature 227: 680-685.
8. TOYKA, K. V., B. LÖWENADLER, K. HEININGER, U. A. BESINGER, K. L. BIRNBERGER, A. FATEH-MOGHADAM & E. HEILBRONN. 1980. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG. J. Neurol. Neurosurg. Psychiatry 43: 836-840.
9. BRETAG, A. H. 1969. Synthetic interstitial fluid for isolated mammalian tissue. Life Sci. 8: 319-329.
10. DEL CASTILLO, J. & B. KATZ. 1954. Quantal components of the end-plate potential. J. Physiol. 124: 560-573.
11. DUDEL, J. 1989. Calcium dependence of quantal release triggered by graded depolarization pulses to nerve terminals on crayfish and frog muscle. Pflügers Arch. 415: 289-298.
12. 2+ inflow to quantal, phasic transmitter release from nerve terminals of frog muscle. Pflügers Arch. 422: 129-142.
13. VAN DER KLOOT, W. & J. MOLGÓ. 1994. Quantal acetylcholine release at the vertebrate neuromuscular junction. Physiol. Rev. 74(4): 899-901.
14. TOYKA, K. V., D. B. DRACHMAN, D. E. GRIFFIN, A. PESTRONK, J. A. WINKELSTEIN, K. H. FISCHBECK & I. KAO. 1977. Myasthenia gravis: study of humoral immune mechanisms by passive transfer to mice. N. Engl. J. Med. 296: 125-131.
15. STERZ, R., R. HOHLFELD, K. RAJKI, M. KAUL, K. HEININGER, K. PEPER & K. V. TOYKA. 1986. Effector mechanisms in myasthenia gravis: endplate function after passive transfer of IgG, Fab, and F(ab′)2 hybrid molecules. Muscle Nerve 9: 305-312.
16. LANG, B., J. NEWSOM-DAVIS, C. PRIOR & D. WRAY. 1983. Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J. Physiol. 344: 335-345.
17. LANG, B., J. NEWSOM-DAVIS, C. PEERS, C. PRIOR & D. W. WRAY. 1987. The effect of myasthenic syndrome antibody on presynaptic calcium channels in the mouse. J. Physiol. 390: 257-270.
18. FUKUOKA, T., A. G. ENGEL, B. LANG, J. NEWSOM-DAVIS, C. PRIOR & D. W. WRAY. 1987. Lambert-Eaton myasthenic syndrome: I. Early morphological effects of IgG on the presynaptic membrane active zones. Ann. Neurol. 22: 193-199.
19. YUKI, N. 1996. Acute paresis of extraocular muscles associated with IgG anti-GQ1b antibody. Ann. Neurol. 39: 668-672.
20. WROBEL, C. J. & D. WATSON. 1992. Plasmapheresis in chronic demyelinating polyneuropathy. N. Engl. J. Med. 326: 1089-1090.
21. LUIJCKX, G. J., J. VLES, M. DE BAETS, B. BUCHWALD & J. TROOST. 1997. Guillain-Barré syndrome in mother and newborn child. Lancet 349: 27.
22. BUCHWALD, B., A. WEISHAUPT, K. V. TOYKA & J. DUDEL. 1998. Pre- and postsynaptic block-ade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals. Eur. J. Neurosci. 10: 101-110.